In addition to the functional prediction from the microbiome, we took a drug repurposing approach to identify drugs with potential to treat IBD using CLUE with the significant DEGs between cGAS KO and WT after DSS treatment. The gene discussed is CGAS; the disease is inflammatory bowel disease.